Zepp Health [ZEPP] vs Vuzix [VUZI] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Zepp Health Corporation wins in 12 metrics, Vuzix Corporation wins in 6 metrics, with 0 ties. Zepp Health Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Zepp Health Corporation Vuzix Corporation Better
P/E Ratio (TTM) -6.56 -5.87 Vuzix Corporation
Price-to-Book Ratio 1.20 7.86 Zepp Health Corporation
Debt-to-Equity Ratio 54.21 2.89 Vuzix Corporation
PEG Ratio 0.09 0.23 Zepp Health Corporation
EV/EBITDA -175.77 -6.42 Vuzix Corporation
Profit Margin (TTM) -15.48% -16.92% Zepp Health Corporation
Operating Margin (TTM) -4.55% -369.00% Zepp Health Corporation
Return on Equity -17.15% -89.68% Zepp Health Corporation
Return on Assets (TTM) -3.34% -50.92% Zepp Health Corporation
Free Cash Flow (TTM) $-25.88M $-21.36M Vuzix Corporation
1-Year Return 103.03% 5.76% Zepp Health Corporation
Price-to-Sales Ratio (TTM) 0.91 31.64 Zepp Health Corporation
Enterprise Value $4.26B $188.60M Zepp Health Corporation
EV/Revenue Ratio 16.44 30.03 Zepp Health Corporation
Gross Profit Margin (TTM) N/A 16.74% N/A
Revenue per Share (TTM) $16 $0 Zepp Health Corporation
Earnings per Share (Diluted) $-2.56 $-0.42 Vuzix Corporation
Beta (Stock Volatility) 1.77 1.37 Vuzix Corporation
Short % of Float 7.68% 20.31% Zepp Health Corporation

Zepp Health Corporation vs Vuzix Corporation Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Zepp Health Corporation7.46%-18.45%-50.83%-68.93%-82.20%-82.02%
Vuzix Corporation8.97%-0.29%13.33%61.14%25.46%-11.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Zepp Health Corporation103.03%0.21%-89.23%-89.70%-89.70%-89.70%
Vuzix Corporation5.76%-40.12%-80.19%-53.43%-53.78%-75.53%

Performance & Financial Health Analysis: Zepp Health Corporation vs Vuzix Corporation

MetricZEPPVUZI
Market Information
Market Cap i$245.12M$205.40M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i55,852787,029
90 Day Avg. Volume i108,171926,886
Last Close$5.04$3.40
52 Week Range$2.25 - $61.85$1.83 - $5.62
% from 52W High-91.85%-39.50%
All-Time High$81.00 (Feb 15, 2021)$32.43 (Apr 05, 2021)
% from All-Time High-93.78%-89.52%
Growth Metrics
Quarterly Revenue Growth0.43%0.76%
Quarterly Earnings GrowthN/A0.76%
Financial Health
Profit Margin (TTM) i-0.15%-0.17%
Operating Margin (TTM) i-0.05%-3.69%
Return on Equity (TTM) i-0.17%-0.90%
Debt to Equity (MRQ) i54.212.89
Cash & Liquidity
Book Value per Share (MRQ)$13.51$0.30
Cash per Share (MRQ)$0.23$0.25
Operating Cash Flow (TTM) i$-25,970,000$-18,789,272
Levered Free Cash Flow (TTM) i$-116,647,485$-9,064,530
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Zepp Health Corporation vs Vuzix Corporation

MetricZEPP (Apr 26, 2026)VUZI (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-6.56-5.87
Forward P/E i231.14-5.69
PEG Ratio i0.090.23
Price to Sales (TTM) i0.9131.64
Price to Book (MRQ) i1.207.86
Market Capitalization
Market Capitalization i$245.12M$205.40M
Enterprise Value i$4.26B$188.60M
Enterprise Value Metrics
Enterprise to Revenue i16.4430.03
Enterprise to EBITDA i-175.77-6.42
Risk & Other Metrics
Beta i1.771.37
Book Value per Share (MRQ) i$13.51$0.30

Financial Statements Comparison: Zepp Health Corporation vs Vuzix Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricZEPP (2025)VUZI (2025)
Revenue/Sales iN/A6.28M
Cost of Goods Sold iN/A7.34M
COGS % of Revenue i-116.9%
Gross Profit iN/A-1.06M
Gross Margin i--16.9%
Research & Development iN/A12.63M
Operating Income (EBIT) iN/A-32.38M
Operating Margin i--515.5%
EBITDA iN/A-29.33M
EBITDA Margin i--467.0%
Pre-Tax Income iN/A-32.27M
Pre-Tax Income % of Revenue i--513.9%
Income Tax iN/A0
Income Tax % of Revenue i-0.0%
Net Income (Profit) iN/A-32.27M
Profit Margin i--513.9%

Balance Sheet & Liquidity Metrics

MetricZEPP (2025)VUZI (2025)
Cash & Equivalents i91.07M21.15M
Total Current Assets i251.56M27.20M
Total Current Assets % of Revenue i-433.0%
Total Current Liabilities i195.37M4.89M
Total Current Liabilities % of Revenue i-77.8%
Long-Term Debt i77.25M502,114
Long-Term Debt % of Revenue i-8.0%
Total Shareholders Equity i252.73M34.68M
Retained Earnings i28.62M-399.86M
Retained Earnings % of Revenue i--6,366.6%
Property, Plant & Equipment i3.46M11.35M

Cash Flow Statement Comparison

MetricZEPP (2025)VUZI (2025)
Operating Cash Flow i-25.97M-21.85M
Operating Cash Flow % of Revenue i--347.8%
Capital Expenditures i-707,000-2.01M
Free Cash Flow i-25.88M-21.36M
FCF Margin i--340.1%
Debt Repayment i-12.60MN/A
Common Stock Repurchase i-2.28M0

Short Interest & Institutional Ownership Analysis

MetricZEPPVUZI
Shares Short i463,06915.89M
Short Ratio i4.1616.17
Short % of Float i7.68%20.31%
Shares Outstanding i7.04M81.10M
Float Shares i96.40M70.78M
% Held by Insiders i7.64%15.82%
% Held by Institutions i63.11%35.45%
% Held by Public i29.25%48.73%

Dividend Analysis & Yield Comparison: Zepp Health Corporation vs Vuzix Corporation

MetricZEPPVUZI
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A